A premium exact match .com for organizations building AI enabled clinical trial platforms, trial intelligence systems, patient recruitment tools, site selection software, clinical data workflows, and regulatory ready trial operations.
Registered in 2016 · Exact match 8-letter .com · Available through Afternic with Buy It Now and lease to own options for AITrials.com · AITrials.ai and AITrials.app may be available only with full package acquisition
AITrials.com is the shortest clean digital shorthand for AI enabled clinical trials. The term naturally maps to AI trial design, AI site selection, AI patient recruitment, AI clinical data review, AI safety monitoring, AI protocol optimization, and AI regulatory workflows.
For organizations building platforms in this space—whether CROs, pharmaceutical AI teams, clinical trial technology companies, or life sciences AI infrastructure firms—this domain offers immediate category alignment. It communicates what you do clearly and credibly to research sites, sponsors, regulators, and investors.
The asset can serve as:
A product umbrella for AI clinical trial software · A corporate initiative brand for AI trial operations · A category hub for thought leadership and lead generation · An investor-facing brand for clinical AI companies · A conference campaign platform · A defensive brand asset to prevent competitor ownership of the obvious category domain
AITrials.com is positioned as a strategic digital asset—not a speculative name. For qualified buyers in pharmaceutical AI, clinical trial technology, or life sciences infrastructure, this domain represents the cleanest possible front door to the AI enabled clinical trials category.
Current regulatory and commercial developments supporting the AI clinical trials category
FDA announced pilot program for AI enabled optimization in clinical trial operations, with comment period extended to June 29, 2026.
Source: FDA.govZS, a global professional services firm, launched Trials.ai—a clinical trial intelligence platform powered by AI and analytics.
Source: ZS.comMedidata announced expanded AI capabilities for clinical trial imaging workflows and safety monitoring in 2026.
Source: Medidata.comAmerican Society of Clinical Oncology (ASCO) and Ryght announced collaboration on AI enabled clinical trial site selection platform.
Source: ASCO.orgAITrials.com says the category in 8 letters or two extremely short words. For pharmaceutical AI teams, CROs, and clinical trial technology platforms, this domain immediately communicates what you do—no explanation needed.
A clean .com matters in regulated clinical, pharmaceutical, and life sciences markets. AITrials.com carries the credibility required for engagement with sponsors, research sites, and regulatory bodies.
Owning the category domain can help prevent a competitor from controlling the obvious digital front door. In a competitive clinical AI market, domain control is a strategic consideration.
AITrials.com is the primary strategic asset. AITrials.ai and AITrials.app may be available only with a full Buy It Now package or separately negotiated full package terms through Afternic.
How organizations in this space might deploy AITrials.com
AITrials.com is available through Afternic. AITrials.com currently redirects to the official Afternic acquisition listing.
Acquisition options may include:
Qualified buyers should contact the Afternic broker through the official listing for complete acquisition details, pricing options, and transaction support.
The transaction is secured through Afternic and GoDaddy supported processes, providing escrow protection and verified transfer for both parties.
Yes. AITrials.com is available for acquisition through the official Afternic listing. AITrials.com currently redirects to the Afternic acquisition page.
AITrials.com is positioned for pharmaceutical companies, Contract Research Organizations (CROs), clinical trial technology platforms, clinical data companies, AI health companies, AI site selection platforms, AI patient recruitment companies, clinical imaging AI companies, and life sciences AI infrastructure firms building products or initiatives in the AI enabled clinical trials category.
Lease to own may be available for AITrials.com through Afternic. Contact the Afternic broker through the official listing to confirm current lease to own terms and options.
No. Lease to own applies to AITrials.com only. AITrials.ai and AITrials.app are not included in the standard lease to own path.
AITrials.ai and AITrials.app may be available only with a full Buy It Now acquisition of the full package or separately negotiated full package terms through Afternic. Contact the Afternic broker for full package pricing and availability.
The acquisition path is handled through Afternic and GoDaddy supported processes. Transactions are secured through industry-standard escrow services, providing protection for both buyer and seller throughout the transfer process.
Yes. Qualified buyers can work through Afternic broker communication for acquisition details, domain verification, and corporate due diligence support.
Click through to AITrials.com (which redirects to the official Afternic listing) or use the “View Afternic Listing” buttons on this page to access the acquisition page directly. From there, you can review pricing options, contact the Afternic broker, and begin the secure acquisition process.
For organizations building AI powered trial platforms, clinical trial intelligence systems, patient recruitment tools, site selection software, clinical data workflows, or regulatory ready trial operations, AITrials.com offers a rare opportunity to own the clearest digital front door to the category.